Skip to main content
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2017 Oct 15;23(3):e12509. doi: 10.1111/anec.12509

Brugada phenocopy caused by a compressive mediastinal tumor

Andrés R Pérez‐Riera 1,, Raimundo Barbosa Barros 2, Rodrigo Daminello‐Raimundo 1, Marianne P C Resende Barbosa 1, Luiz C de Abreu 1
PMCID: PMC6931846  PMID: 29034526

Abstract

Recently, it has been shown that even experts in electrocardiography cannot differentiate the electrocardiographic pattern of genuine Brugada syndrome (BrS) from Brugada phenocopy (BrP). For this reason, this differentiation depends on the presence of established criteria both for BrS and BrP. In this manuscript, we present a patient with type 1 Brugada electrocardiographic pattern caused by expansive anterior mediastinal non‐Hodgkin's lymphoma (NHL) with mechanical compression on the right ventricular outflow tract. The electrocardiographic pattern disappeared rapidly after antineoplastic measures.

Keywords: Brugada phenocopy, Brugada syndrome, non‐Hodgkin's lymphoma, sodium channel blocker

1. CASE REPORT

An elderly Caucasian woman (79 years old) was admitted to the emergency room with complaint of precordial pain for 6 months with epigastric irradiation at rest, worsening in intensity and duration in the last 2 days associated with dyspnea and dry cough. 30 days before she had a syncopal episode with palpitations.

Negative family history for sudden death or syncope in first‐degree relatives <45 years.

Physical examination: sinus rhythm, heart rate 96 bpm, diffuse hypophonesis, left basal crackles in the left lung and auscultation over the right lung produced a very muffled sound, painful distended abdomen palpation in the right hypochondrium, palpable liver at 3 cm below the right costal ridge. Palpable cervical ganglia on the right side.

Discrete troponin elevation (0.320) with normal CK‐MB; normal electrolytes.

Initial 12‐lead electrocardiogram (ECG) was performed (Figure 1), which led to thinking of right ventricle (RV) myocardial infarction. Coronary angiography revealed 70% proximal obstruction in the right coronary artery (RCA) (Figure 2) and ventriculography did not reveal dyskinesis in any ventricle. Successful stent implantation was placed in the RCA (TIMI 3 and BLUSH 3). Even with the success of the procedure, serial ECGs did not show reversion of ST elevation (STE) in the right precordial leads.

Figure 1.

Figure 1

Initial ECG. STE in aVR and from V1–V3 decreasing progressively (this characteristic differentiates RV infarction from anteroseptal LV infarction). Concomitantly, ST depression is observed in inferior and lateral walls. Conclusion: type 1 Brugada ECG pattern

Figure 2.

Figure 2

Percutaneous coronary intervention. Occlusion of the proximal RCA (a), TIMI3 flow in the dominant RCA after insertion of drug‐eluting stent (b)

Posteroanterior chest x‐ray (Figure 3) showed a large pleural effusion on the right side that disappeared after treatment.

Figure 3.

Figure 3

Posteroanterior chest x‐ray. Large pleural effusion before (a) and after treatment (b)

Computed tomography of the thorax showed an invasive expansive process (tumor) of the right pulmonary artery and the RV outflow tract (RVOT) (Figure 4).

Figure 4.

Figure 4

The computed tomography indicates the tumor extension (arrow)

Echocardiogram showed mild concentric left ventricle (LV) hypertrophy (septum and free wall = 12 mm), normal ventricular function (LV ejection fraction = 73%); chambers with normal dimensions; global contraction and preserved segment; moderate pericardial effusion without diastolic restriction; pulmonary artery systolic pressure = 65 mmHg.

Transcarinal needle aspiration biopsy revealed NHL. Chemotherapy treatment was started, associated with radiotherapy and immunotherapy with monoclonal antibodies and cytokines, which led to the reversal of type 1 Brugada ECG pattern (Figure 5). As an indispensable element for this diagnosis, we performed a provocative ajmaline test that was negative.

Figure 5.

Figure 5

ECG normalization after oncologic therapy. Low QRS voltage in the limb leads (<5 mm) and precordial leads (<10 mm), ST depression in inferior and lateral precordial leads

2. DISCUSSION

In the second consensus conference about BrS, the admitted criteria are: absence of apparent structural heart disease; absence of drugs effects, electrolyte disturbance and coronary artery disease; documented polymorphic ventricular tachycardia (PVT)/ventricular fibrillation (VF); family history of syncope and/or sudden cardiac death at <45 years in first‐degree relatives; type 1 Brugada ECG pattern in proband and family members; induction of PVT/VF with programmed electrical stimulation; and syncope, cardiac arrest or nocturnal agonal respiration (Antzelevitch et al., 2005).

Several conditions have been suggested to mimic this ECG pattern without the same clinical implications. In our patient, the ECG pattern was most likely due to tumor compression of the RVOT, since the ECG normalized after tumor disappearance. It is difficult to decide if this “secondary” form of Brugada‐like electrocardiographic changes can result in an increased risk for developing ventricular tachyarrhythmia in asymptomatic patients with BrS.

To our knowledge, a relation between RVOT compression by extracardiac mass and type 1 Brugada ECG pattern has been reported for the first time in 1999 by Tarín et al. (Tarin, Farre, Rubio, Tunon, & Castro‐Dorticos, 1999), but in this case, they did not perform the sodium channel block test.

The present case has all the necessary criteria for BrP (Anselm, Gottschalk, & Baranchuk, 2014): type‐1 Brugada ECG pattern, underlying identifiable condition, ECG normalization after resolution of the underlying condition, low clinical pretest probability of true BrS determined by a lack of symptoms, medical and family history, negative ajmaline provocative test.

3. CONCLUSION

We presented a case of mediastinal non‐Hodgkin's lymphoma that compressed the RVOT originating a type 1 Brugada ECG pattern. After the treatment and lymphoma reversal, this pattern disappeared. The negative provocative ajmaline test indicates low probability of Brugada syndrome.

CONFLICT OF INTEREST

None.

Pérez‐Riera AR, Barros RB, Daminello‐Raimundo R, Rezende Barbosa MPC, de Abreu LC. Brugada phenocopy caused by a compressive mediastinal tumor. Ann Noninvasive Electrocardiol. 2018;23:e12509 10.1111/anec.12509

REFERENCES

  1. Anselm, D. D. , Gottschalk, B. H. , & Baranchuk, A. (2014). Brugada phenocopies: Consideration of morphologic criteria and early findings from an international registry. Canadian Journal of Cardiology, 30(12), 1511–1515. [DOI] [PubMed] [Google Scholar]
  2. Antzelevitch, C. , Brugada, P. , Borggrefe, M. , Brugada, J. , Brugada, R. , Corrado, D. , … Wilde, A. (2005). Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation, 111(5), 659–670. [DOI] [PubMed] [Google Scholar]
  3. Tarin, N. , Farre, J. , Rubio, J. M. , Tunon, J. , & Castro‐Dorticos, J. (1999). Brugada‐like electrocardiographic pattern in a patient with a mediastinal tumor. Pacing and Clinical Electrophysiology, 22(8), 1264–1266. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology : The Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES